Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
Oral Oncology|June 18, 2016
Impact of post-chemoradiotherapy superselective/selective neck dissection on patient reported quality of lifeKyle Wang, Robert J Amdur, William M Mendenhall, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentationKyle Wang, Dwight E Heron, David A Clump, et al.Oral Oncology|August 12, 2017
Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancersDominic H Moon, Sung Ho Moon, Kyle Wang, et al.International Journal of Radiation Oncology, Biology, Physics|December 28, 2020
Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose ResponseKyle Wang, Panayiotis Mavroidis, Trevor J Royce, et al.International Journal of Radiation Oncology, Biology, Physics|February 24, 2025
Boswellia Serrata for Cerebral Radiation Necrosis After Radiosurgery for Brain MetastasesRituraj Upadhyay, Ahmed Nader Mohammed Elguindy, Laura Salts, et al.Oral Oncology|March 3, 2018
Pitfalls of post-treatment PET after de-intensified chemoradiotherapy for HPV-associated oropharynx cancer: Secondary analysis of a phase 2 trialKyle Wang, Terence Z Wong, Robert J Amdur, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 GyKyle Wang, Michael J Eblan, Allison M Deal, et al.Iscience|June 30, 2025
Single-cell imaging of protein dynamics of paralogs reveals sources of gene retentionRohan Dandage, Mikhail Papkov, Brittany M Greco, et al.Head & Neck|December 17, 2018
Shoulder symptoms and quality of life impact of limited neck dissection after de-intensified chemoradiotherapy: Secondary analysis of two prospective trialsKyle Wang, Dominic H Moon, Robert J Amdur, et al.Elife|February 4, 2025
The PRC2.1 subcomplex opposes G1 progression through regulation of CCND1 and CCND2Adam D Longhurst, Kyle Wang, Harsha Garadi Suresh, et al.Pageof 6